MT2(Melanotan II)Powder Promotes Skin Tanning CAS:121062-08-6
Melanotan II, colloquially known as MT-II or the "Barbie Drug," is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH). Developed in the 1980s at the University of Arizona, its initial purpose was to reduce skin cancer risk by stimulating melanin production without UV exposure.
Introduction to Melanotan II (MT-II)
Melanotan II, colloquially known as MT-II or the "Barbie Drug," is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH). Developed in the 1980s at the University of Arizona, its initial purpose was to reduce skin cancer risk by stimulating melanin production without UV exposure. Unlike natural α-MSH, MT-II exhibits enhanced stability and prolonged activity due to structural modifications, making it a potent agent in cosmetic and experimental medical applications.
Distinctive Features of MT-II
●Synthetic Peptide Structure: Composed of 7 amino acids, MT-II is engineered to resist enzymatic degradation, enhancing its half-life.
●Multi-Receptor Agonism: Binds to melanocortin receptors (MC1R-MC5R), influencing pigmentation, libido, and appetite.
●Lyophilized Form: Sold as a sterile, freeze-dried powder requiring reconstitution with bacteriostatic water.
●Stability: Stable at room temperature when unmixed but degrades post-reconstitution, necessitating refrigeration.
Applications Beyond Cosmetic Tanning
●Erythropoietic Protoporphyria (EPP): Alleviates photosensitivity in this rare genetic disorder by increasing melanin.
●Aphrodisiac Effects: Activation of MC4R in the hypothalamus enhances sexual arousal, studied for erectile dysfunction.
●Appetite Modulation: Early research suggests MC4R involvement in satiety, though less pronounced than MT-II's other effects.
●Neuroprotective Research: Preclinical studies explore its role in reducing inflammation in neurodegenerative diseases.
Benefits with Nuanced Considerations
●UV-Independent Tanning: Stimulates eumelanin, offering a base tan that may reduce UV exposure needs by 50%.
●Uniform Pigmentation: Addresses patchy tanning, beneficial for individuals with vitiligo or pale skin.
●Psychological Well-being: Users report improved self-esteem linked to a tan appearance.
●Libido Enhancement: Off-label use for sexual dysfunction, though anecdotal.
Dosage Protocol & Cycling Strategies
●Initial Phase: Microdosing (0.25–0.5 mg/day subcutaneously) for 3–5 days to assess tolerance, minimizing nausea.
●Loading Phase: Incremental increase to 1 mg/day over 10 days until desired pigmentation.
●Maintenance: 1–2 mg weekly, adjusted for sun exposure.
●Cycle Duration: 4–8 weeks, with breaks to prevent receptor desensitization.
Pharmacokinetics: Half-Life & Metabolism
●Half-Life: ~36 hours, enabling alternate-day dosing.
●Metabolism: Hepatic breakdown into inactive metabolites, renal excretion.
●Accumulation Risk: Chronic use may lead to hyperpigmentation or mole darkening.
PTC: Precautions, Toxicology, & Contraindications
●Precautions:
○Self-Administration Risks: Sterile technique failure can cause abscesses.
○Mole Monitoring: Regular dermatological checks for dysplastic changes.
●Toxicology:
○Acute Overdose: Hypertension, severe nausea (rare above 2 mg).
○Chronic Use: Limited data; anecdotal reports of appetite loss.
●Contraindications:
○Melanoma history, cardiovascular disorders, pregnancy.
○Interactions with PDE5 inhibitors (e.g., sildenafil) due to additive vasodilation.
Controversies & Ethical Considerations
●Regulatory Gray Zones: Sold as "research chemicals," bypassing FDA/EMA approval.
●Black Market Prevalence: Unregulated production risks contaminants.
●Ethical Dilemmas: Promotion of unrealistic beauty standards and medicalization of aesthetics.
Comparative Analysis with Alternatives
●MT-II vs. Topical DHA: Unlike dihydroxyacetone (DHA)-based tans, MT-II induces physiological melanogenesis, lasting weeks post-cycle.
●MT-II vs. MT-I: MT-II's broader receptor activation offers libido effects but more side effects.
User Guidelines & Best Practices
●Reconstitution: Use 1–2 mL bacteriostatic water; swirl gently to preserve peptide integrity.
●Storage: Reconstituted solution stable for 20 days at 4°C.
●Injection Sites: Rotate between abdomen, thighs, and deltoids to prevent lipoatrophy.
Future Directions & Research
●Targeted Delivery Systems: Nasal sprays or transdermal patches to replace injections.
●Oncological Applications: Exploring MC1R agonism in melanoma prevention.
Clinical Data
|
Trade names |
MT2 |
|
CAS |
121062-08-6 |
|
Molar mass |
1024.180 |
|
Formula |
C50H69N15O9 |
|
Purity |
Above 98% |
|
Apprarance |
White crystalline powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
Melanotan II represents a fusion of cosmetic innovation and biochemical ingenuity. While its tanning efficacy is undeniable, its unregulated status demands cautious use. Ongoing research may legitimize its medical applications, but current users must navigate its benefits and risks judiciously.
Hot Tags: mt2(melanotan ii)powder promotes skin tanning cas:121062-08-6, China mt2(melanotan ii)powder promotes skin tanning cas:121062-08-6 manufacturers, suppliers, factory
